Fielder Capital Group LLC bought a new stake in Neuronetics, Inc. (NASDAQ:STIM – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 22,797 shares of the company’s stock, valued at approximately $66,000. Fielder Capital Group LLC owned approximately 0.08% of Neuronetics at […]
Fielder Capital Group LLC bought a new stake in shares of Neuronetics, Inc. (NASDAQ:STIM – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor bought 22,797 shares of the company’s stock, valued at approximately $66,000. Other large investors also recently bought and sold shares of the company. FNY Investment Advisers LLC purchased […]
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 94,600 shares, a growth of 77.8% from the March 15th total of 53,200 shares. Based on an average daily volume of 199,100 shares, the days-to-cover ratio is […]
Neuronetics (NASDAQ:STIM – Get Free Report)‘s stock had its “market perform” rating restated by William Blair in a note issued to investors on Tuesday, RTT News reports. Separately, Piper Sandler reiterated an “overweight” rating and issued a $8.00 target price (up previously from $7.00) on shares of Neuronetics in a research report on Wednesday, March […]
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) CEO Keith J. Sullivan sold 20,851 shares of the business’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $3.23, for a total value of $67,348.73. Following the completion of the transaction, the chief executive officer now directly […]